TMU-Shuang-Ho Hospital
Taipei, Taiwan
NCT Number: NCT03484793
Medication errors are common, life-threatening, costly but preventable. Information technology and automated systems are highly efficient for preventing medication errors and therefore widely employed in hospital settings. In this study, investigators would perform a cluster randomized controlled trial of a clinical reminding system that uses DNN and Probabilistic models to detect and notify physicians of inappropriate prescriptions, giving them the opportunity to correct these gaps and increase prescriptions completeness. This study aim is to assess whether or not this system would improve prescription notation for a broad array of patient conditions.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Taipei, Taiwan
This paper focuses on "Big data" in the knowledge base, using "Data minig" study of DM (Disease-Medication) and MM (Medication-Medication) of relevance to develop associated decision resources system-"the intelligent safety system" (Advanced Electronic Safety of Prescriptions,AESOP Model), and test the system in the clinical environment in hospital can assist physicians when open orders reduce medication errors, the system is named "AESOP Model".
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Investigators develop an electronic reminder in CPOE system which notifies physicians when there appears to be an inappropriate prescription. At the time, a physician saves a typed prescription, our system analyzes the patient's medications, diseases and uses the knowledge base to determine whether a medication is uncommonly prescribed to all diseases in a given prescription. If the system detects the common associations of medications and diseases in a given prescription, it considers an appropriate prescription, and, if not, an actionable reminder is shown onscreen. To the right of each suggested uncommon medication is a reason why the reminder is appearing. Physicians can accept the reminder or ignore the reminder.
Time frame: 3 months
The primary outcome of this study is the acceptance rate of the reminder, defined as the number of reminders accepted divided by number of unique reminders presented. In certain instances, physicians might see the same reminder serially, so we aggregate presentations and acceptance of the same reminder for the same patients' prescriptions in our calculation of the acceptance rate.
Time frame: 3 months
As a secondary outcome, we measure the number of inappropriate prescriptions rate documented in the two groups during the two time periods and calculate the unadjusted relative rate of inappropriateness notation in the intervention group by comparing the number of inappropriateness recorded in the intervention arm during the intervention period to all other groups. The unadjusted relative rate is defined as the ratio (errorsintervention-post/errorscontrol-post)/ (errorsintervention-pre/errorscontrol-pre).
Taipei Medical University
Other
Using Big Data and Deep Neural Network to Prevent Medication Errors
Acronym: AESOP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02439775
Cardiovascular Diseases, Hypertension
Huntsville, Alabama, United States
View Trial DetailsNCT07735468
Behavior, Cardiovascular Diseases
Osuna, Sevilla, Spain
View Trial DetailsNCT00837122
Cardiovascular Diseases, Diabetes
Accra, Ghana
View Trial DetailsNCT05873153
Cardiovascular Diseases, Hypertension
Mankato, Minnesota, United States
View Trial Details